About us :
Jodas is a Global, specialty, innovation driven, emerging, generic bio- pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2006 in India, and today Jodas is a modern, research driven organization that has quality and affordability at the heart of its activities.
JEPL is having EU GMP certification of Oncology (orals),Contrast Media (SVP & LVP) and facility for Cephalosporins (DPI) currently delivering the products like Anti-Cancer and Antibiotics, Contrast media
JODAS FOCUSES ITS OPERATIONS ON FOUR SPECIALITY THERAPEUTIC SEGMENTS:
Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective and affordable generic formulations to the market, touching millions of lives with good health.
Jodas has 40+ approved products in targeted emerging markets with State-of-the-art world-class manufacturing facilities and has successfully commercialized 7 million Injectables in the year 2014, with unparalleled customer satisfaction.
Focused to grow further in Emerging markets. The future endeavor is to be a Global generic player in highly regulated markets. We are committed to be “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with branded generic formulations of uncompromising quality.
Jodas has constantly upped the benchmark in uncompromising quality, with a pulse on rapidly changing innovation to commercialization landscape through our selection of a product range of affordable medicines and speed-to-the-market, along with our partners and Global supply chain.
We continuously evolve our business focus with a customer–centered portfolio of niche and technologically challenging products from specialty and therapeutic segments.Our continuous focus on innovation and quality drives us to fulfill the unmet medical needs of the healthcare community and make the dreams of millions of people across the world come true with much needed medicines at an affordable value.